GF Fund Management’s Legend Biotech LEGN Stock Holding History

GF Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.6K	Sell	1,788 -93	-5%	-$2.51K	﹤0.01%	386
2026 Q1	$34K	Buy	1,881 +227	+14%	+$4.33K	﹤0.01%	446
2025 Q4	$36K	Sell	1,654 -158	-9%	-$4.53K	﹤0.01%	438
2025 Q3	$59.1K	Sell	1,812 -280	-13%	-$10.3K	﹤0.01%	377
2025 Q2	$74.2K	Hold	2,092	–	–	﹤0.01%	388
2025 Q1	$71K	Buy	2,092 +377	+22%	+$13.5K	﹤0.01%	389
2024 Q4	$55.8K	Buy	+1,715	New	+$71K	﹤0.01%	381

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

GF Fund Management's LEGN Position: Q2 2026 in Review

GF Fund Management reduced its Legend Biotech (LEGN) stake by 4.9% in Q2 2026, selling an estimated $2.51K and leaving 1,788 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

GF Fund Management first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.2K in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

GF Fund Management held 1,788 shares of Legend Biotech worth $51.6K as of Q2 2026.
GF Fund Management sold 93 Legend Biotech shares in Q2 2026, an estimated $2.51K.
Legend Biotech made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #386 holding.
GF Fund Management first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Legend Biotech position peaked at $74.2K in Q2 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.